Modelling cortical cataractogenesis XVIII. In vitro, diabetic cataract reduction by venoruton. A flavonoid which prevents lens opacification

Acta Ophthalmologica Scandinavica

Volumn 74, Issue 4, 1996, Pages 372-378

  Kilic, Fusun ^a   Bhardwaj, Ratan ^a   Trevithick, John R ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Aldose reductase; Antioxidant; Cataract; Enzyme leakage; Hydroxyethylrutoside; In vitro lens damage; Lactate dehydrogenase; Membrane damage; Peroxide; Superoxide

Indexed keywords

FLAVONOID; LACTATE DEHYDROGENASE; MONOXERUTIN;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CATARACT; CATARACTOGENESIS; CELL DAMAGE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SURGICAL MICROSCOPE;

EID: 0029782349     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.1996.tb00712.x     Document Type: Article

References (38)

1. Allen A & Tooke JE (1990): Effects of hydroxyethyl-rutosides in diabetes mellitus. Phlebology 5 (Suppl 1): 27-31.
2. Balant LP, Wermeille M & Griffiths LA (1984): Metabolism and pharmacokinetics of hydroxyethylated rutosides in animals and man. Drug Metab Drug Interact 5: 1-23.
3. Barrow A & Griffiths LA (1974): Metabolism of the hydroxyethylrutosides II. Excretion and metabolism of 3′,4,′7-tri-O-(β-hydroxy-ethyl)rutoside and related compounds in laboratory animals after parenteral administration. Xenobiotica 4: 1-16.
4. Belcaro G & Candiani C (1991): Chronic ef fects of O-(αhydroxyethyl)rutosides on microcirculation and capillary filtration in diabetic microangiopathy. Current Therapeutic Res 49: 131-139.
5. Bianca DW (1992): LDH activity as a measure of the toxicity of G418 on CHO-K1 cells. Mol Biol Cell 3: 177a-1029.
6. Bhuyan KC & Bhuyan DK (1984): Molecular mechanism of cataractogenesis III: Toxic metabolites of oxygen as indicators of lipid peroxidation and cataract. Curr Eye Res 3: 67-82.
7. Chand D, El-Aguizy HK, Richards RD & Varma S (1982): Sugar cataracts in vitro: Implications of oxidative stress and aldose reductase I. Exp Eye Res 35: 491-497.
8. Chylack LT (1978): Classification of human cataracts. Arch Ophthalmol 96: 838-892.
9. Cohen MP (1986): In Diabetes and protein glycosylation. Springer Verlag NY.
10. Crabbe MJC, Petchey M & Wolff SP (1986a): Monosaccharide-induced NADPH oxidation (aldose reductase activity) and the uptake of sorbinil and myoinositol in incubated rat lenses. Lens Res 3: 69-91.
11. Crabbe MJC, Wolff SP & Lloyd P (1986b): Monosaccharide autoxidation, cataract and aldose reductase activity. In: Duncan G (ed). The Lens: Transparency and Cataract (Topics in ageing research in Europe, vol 6) pp 119-126. Eurgae Publications, The Netherlands.
12. Creighton MO, Stewart-DeHaan PJ, Ross WM, Sanwal M & Trevithick JR (1980): Modelling cortical cataractogenesis: 1. in vitro effects of glucose, sorbitol and fructose on intact rat lenses in medium 199. Can J Ophthalmol 15: 183-188.
13. +-ATPase. Proc Natl Acad Sci USA 80: 2044-2048.
14. Jernigan HM & Laranang A (1984): Effects of riboflavin-sensitized photooxidation on choline metabolism in cultured rat lenses. Curr Eye Res 3: 121-126.
15. Karlsson J, Frith K, Sjodin B, Gollnick PD & Saltin B (1974): Distribution of LDH isoenzymes in human skeletal muscle. Scand J Clin Lab Invest 33: 307-312.
16. Kilic F, Mitton K, Dzialoszynski T, Sanford SE & Trevithick JR (1994): Modelling cortical cataractogenesis 14: Reduction in lens damage in diabetic rats by a dietary regimen combining vitamins C and E and β-carotene. In: Hockwin O & Sasaki K (eds). Cataract Pathogenesis: Results of epidemiological studies and experimental models. Dev Ophthalmol 26: 63-72. Karger, Basel.
17. Kilic F & Trevithick JR (1995): Modelling cortical cataractogenesis 16. Leakage of lactage dehydrogenase: A new method for following cataract development in cultured lenses. Biochem Mol Biol Int 35: 1143-1152.
18. Kinoshita JH (1965): Pathways of glucose metabolism in the lens. Invest Ophthal Vis Sci 4: 619-628.
19. Kinoshita JH, Varma SD & Fukui HN (1976): Aldose reductase in diabetes. Jap J Ophthalmol 20: 399-410.
20. Linklater HA, Dzialoszynski T, McLeod HL, Sanford SE & Trevithick JR (1986): Modelling cortical cataractogenesis. VIII. Effects of butylated hydroxytoluene (BHT) in reducing protein leakage from lenses in diabetic rats. Exp Eye Res 43: 305-313.
21. Linklater HA, Dzialoszynski T, McLeod HL, Sanford SE & Trevithick JR (1990): Modelling cortical cataractogenesis. XI. Vitamin C treatment reduces α-crystallin leakage from lenses in diabetic rats. Exp Eye Res 51: 241-247.
22. Mitton KP, Dean PAW, Dzialoszynski T, Xiong H, Sanford SE & Trevithick JR (1993): Modelling cortical cataractogenesis 13. Early effects on lens ATP/ADP and glutathione in the streptozotocin rat model of the diabetic cataract. Exp Eye Res 56: 187-198.
23. Moss DW, Henderson AR & Kachmar JF (1986): 'Enzymes'. In: Tietz NW (ed). Textbook of Clinical Chemistry, Chapter 5. WB Saunders Company.
24. Norusis MJ (1988): SPSS. In: SPSS/PC+ V2.0 Base Manual. SPS Inc., Chicago, IL.
25. Ogiso M, Irie A, Kubo H, Komoto M, Matsuno T, Koide Y & Hoshi M (1993): Characterization of neutral glycosphingolipids in human cataractous lens. J Biol Chem 268: 13242-13247.
26. Reddy VN, Lin L-R, Giblin FJ, Lou M, Kador PF & Kinoshita JH (1992): The efficacy of aldose reductase inhibitors on polyol accumulation in human lens and retinal pigment epithelium in tissue culture. J Ocular Pharm 8: 43-52.
27. Ross WM, Creighton MO, Stewart-DeHaan PJ, Sanwal M, Hirst M & Trevithick JR (1982): Modelling cortical cataractogenesis. 3. Effects of vitamin E on cataractogenesis in diabetic rats. Can J Ophthalmol 17: 61-66.
28. Ross WM, Creighton MO, Inch WR & Trevithick JR (1983): Radiation cataract in vitro reduced by vitamin E. Exp Eye Res 36: 645-653.
29. Trevithick JR, Linklater HA, Dzialoszynski T, McLeod H, Sanford SE & Robertson J McD (1994): Modelling cortical cataractogenesis 15: use of combined dietary anti-oxidants to reduce cataract risk. In: Hockwin O & Sasaki K (eds). Cataract Pathogenesis: Results of epidemiological studies and experimental models. Dev Ophthalmol 26: 72-82. Karger, Basel.
30. Trevithick JR & Dzialoszynski T (1994): A new technique for enhancing luminol luminescent detection of free radicals and reactive oxygen species. Biochem Mol Biol Int 33: 1179-1190.
31. Tumminia SJ, Qin C, Zigler JS & Russel P (1994): The integrity of mammalian lenses in organ culture. Exp Eye Res 58: 367-374.
32. Varma SD, Mikuni I & Kinoshita JH (1975): Flavonoids as inhibitors of lens aldose reductase. Science 188: 1215-1216.
33. Varma SD & Kinoshita JH (1976): Inhibition of lens aldose reductase by flavonoids - their possible role in the prevention of diabetic cataract. Biochem Pharm 25: 2505-2513.
34. Varma SD, Ets TK & Richards RD (1977): Protection against superoxide radicals in rat lens. Ophthalmic Res 9: 421-431.
35. Varma SD, Chand D, Sharma YR, Kuck JF & Richards RD (1984): Oxidative stress on the lens and cataract formation: role of light and oxygen. Curr Eye Res 3: 35-58.
36. Wadworth AN & Faulds D (1992): Hydroxyethylrutoside. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders. Drugs 44: 1013-1032.
37. Wolff SP & Dean RT (1987): Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J 245: 243-250.
38. Zigler JS & Goosey JD (1984): Singlet oxygen as a possible factor in human senile nuclear cataract development. Curr Eye Res 3: 59-66.